查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594434

無針糖尿病護理市場：按設備類型、最終用戶分類 - 2025-2030 年全球預測

Needle Free Diabetes Care Market by Device Type (Insulin Infuser, Insulin Patches, Insulin Pens), End User (Consumer, Diagnostic Center, Hospitals & Clinic) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

無針糖尿病護理市場2023年估值為138.7億美元，預計到2024年將達到161.1億美元，複合年成長率為16.26%，預計到2030年將達到398.3億美元。

無針糖尿病護理市場範圍包括針對傳統無針糖尿病管理的設備和技術，例如連續血糖監測（CGM）系統、胰島素幫浦和噴射注射器。這些技術的需求源自於傳統針刺方法帶來的不適和不便，旨在提高患者的依從性和生活品質。這些技術主要由醫院、診所和家庭護理等最終用戶應用，用於監測血糖值和管理胰島素。糖尿病盛行率不斷上升、對非侵入性監測設備的需求不斷增加、醫療保健技術的進步以及患者意識的提高對市場產生了重大影響。研發投資的激增和主要企業之間的策略聯盟代表了促進創新和提供差異化產品的潛在商機。糖尿病人口不斷增加、醫療基礎設施不斷發展的新興市場也代表著開拓的商機。然而，市場面臨無針器材高成本、法規要求嚴格、新興市場意識缺乏等挑戰。此外，技術限制和可靠資料的準確性可能會阻礙採用率。為了推動成長並克服這些挑戰，公司正在利用基於奈米技術的輸送系統、用於持續監控的智慧穿戴設備以及用於個人化醫療保健解決方案的物聯網和糖尿病護理設備整合等技術。市場充滿活力且競爭激烈，技術進步不斷改變格局。公司可以透過投資於方便用戶使用的設計、確保負擔能力以及提高產品的準確性和效率來提高競爭力。此外，我們對以患者為中心的方法的關注以及與醫療保健提供者的合作將有助於推動無針糖尿病護理領域的廣泛採用和市場擴張。

主要市場統計
基準年[2023] 138.7億美元
預測年份 [2024] 161.1億美元
預測年份 [2030] 398.3億美元
複合年成長率（%） 16.26%

市場動態：快速發展的無針糖尿病護理市場的關鍵市場洞察

無針糖尿病護理市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 糖尿病和肥胖人口增加
    • 用於疾病管理的智慧型手機應用程式的增加
    • 提高對糖尿病及其治療的認知
  • 市場限制因素
    • 對與該設施相關的高成本和技術錯誤的擔憂
  • 市場機會
    • 糖尿病治療技術的進步
    • 擴大無針糖尿病治療的採用
  • 市場挑戰
    • 穿刺和針刺傷感染的風險很高

波特五力：駕馭無針糖尿病照護市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解無針糖尿病護理市場的外部影響

外部宏觀環境因素在塑造無針糖尿病護理市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解無針糖尿病護理市場的競爭格局

對無針糖尿病護理市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣無針糖尿病護理市場供應商的績效評估

FPNV定位矩陣是評估無針糖尿病護理市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了無針糖尿病護理市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，無針糖尿病護理市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 糖尿病和肥胖人口增加
      • 用於疾病管理的智慧型手機應用程式的增加
      • 提高對疾病和治療方法的認知
    • 抑制因素
      • 對與該設施相關的高成本和技術錯誤的擔憂
    • 機會
      • 糖尿病照護的技術進步
      • 無針糖尿病治療的採用率增加
    • 任務
      • 蜇傷和針刺感染的風險很高
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章按設備類型分類的無針糖尿病護理市場

  • 胰島素注射器
  • 胰島素貼片
  • 胰島素筆
  • 胰島素幫浦
  • 噴射注射器

第 7 章 無針糖尿病護理市場：依最終使用者分類

  • 消費者
  • 診斷中心
  • 醫院/診所

第8章北美和南美無針糖尿病護理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區無針糖尿病照護市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的無針糖尿病護理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Akra Dermojet
  • Antares Pharma, Inc.
  • Bioject Medical Technologies Inc.
  • Echo Therapeutics Inc.
  • European Pharma Group BV
  • Injex Pharma AG
  • MannKind Corporation
  • Medical International Technology, Inc.
  • Pharmajet, Inc.
  • The 3M Company
Product Code: MRR-036C5CF3B492

The Needle Free Diabetes Care Market was valued at USD 13.87 billion in 2023, expected to reach USD 16.11 billion in 2024, and is projected to grow at a CAGR of 16.26%, to USD 39.83 billion by 2030.

The scope of the needle-free diabetes care market involves devices and technologies aimed at diabetes management without the use of traditional needles, including continuous glucose monitoring (CGM) systems, insulin pumps, and jet injectors. The necessity of these technologies arises from the discomfort and inconvenience associated with traditional needle-based methods, aiming to enhance patient compliance and quality of life. They are applied in monitoring blood glucose levels and administering insulin, primarily by end-users such as hospitals, clinics, and home care settings. The market is significantly influenced by the increasing prevalence of diabetes, growing demand for non-invasive monitoring devices, advancements in healthcare technologies, and rising patient awareness. A surge in R&D investments and strategic collaborations between key players are potential opportunities, as they promote innovation and offer differentiated products. Emerging markets with a growing diabetic population and evolving healthcare infrastructures also present untapped opportunities. However, the market faces challenges such as the high costs of needle-free devices, stringent regulatory requirements, and a lack of awareness in developing regions. Furthermore, technological limitations and reliable data accuracy can impede adoption rates. To foster growth and overcome these challenges, businesses can focus on innovative areas such as nanotechnology-based delivery systems, smart wearable devices for continuous monitoring, and integrating IoT with diabetes care devices for personalized healthcare solutions. The market is dynamic and competitive, with technological advancements consistently shaping its landscape. Companies can gain a competitive edge by investing in user-friendly designs, ensuring affordability, and enhancing the precision and efficiency of their offerings. The emphasis on patient-centric approaches and collaborations with healthcare providers can also promote widespread adoption and market expansion in the needle-free diabetes care domain.

KEY MARKET STATISTICS
Base Year [2023] USD 13.87 billion
Estimated Year [2024] USD 16.11 billion
Forecast Year [2030] USD 39.83 billion
CAGR (%) 16.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Needle Free Diabetes Care Market

The Needle Free Diabetes Care Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of diabetes and obese population
    • Increasing number of smartphone apps for disease management
    • Rising awareness regarding the disease and the treatments
  • Market Restraints
    • High cost associated with the facility and concerns regarding technical errors
  • Market Opportunities
    • Technological advancements for diabetes care
    • Growing adoption of needle-free diabetes management
  • Market Challenges
    • High risk of infection because of poking and needle-stick injuries

Porter's Five Forces: A Strategic Tool for Navigating the Needle Free Diabetes Care Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Needle Free Diabetes Care Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Needle Free Diabetes Care Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Needle Free Diabetes Care Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Needle Free Diabetes Care Market

A detailed market share analysis in the Needle Free Diabetes Care Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Needle Free Diabetes Care Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Needle Free Diabetes Care Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Needle Free Diabetes Care Market

A strategic analysis of the Needle Free Diabetes Care Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Needle Free Diabetes Care Market, highlighting leading vendors and their innovative profiles. These include Akra Dermojet, Antares Pharma, Inc., Bioject Medical Technologies Inc., Echo Therapeutics Inc., European Pharma Group BV, Injex Pharma AG, MannKind Corporation, Medical International Technology, Inc., Pharmajet, Inc., and The 3M Company.

Market Segmentation & Coverage

This research report categorizes the Needle Free Diabetes Care Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, and Jet Injectors.
  • Based on End User, market is studied across Consumer, Diagnostic Center, and Hospitals & Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of diabetes and obese population
      • 5.1.1.2. Increasing number of smartphone apps for disease management
      • 5.1.1.3. Rising awareness regarding the disease and the treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the facility and concerns regarding technical errors
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements for diabetes care
      • 5.1.3.2. Growing adoption of needle-free diabetes management
    • 5.1.4. Challenges
      • 5.1.4.1. High risk of infection because of poking and needle-stick injuries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Needle Free Diabetes Care Market, by Device Type

  • 6.1. Introduction
  • 6.2. Insulin Infuser
  • 6.3. Insulin Patches
  • 6.4. Insulin Pens
  • 6.5. Insulin Pumps
  • 6.6. Jet Injectors

7. Needle Free Diabetes Care Market, by End User

  • 7.1. Introduction
  • 7.2. Consumer
  • 7.3. Diagnostic Center
  • 7.4. Hospitals & Clinic

8. Americas Needle Free Diabetes Care Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Needle Free Diabetes Care Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Needle Free Diabetes Care Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akra Dermojet
  • 2. Antares Pharma, Inc.
  • 3. Bioject Medical Technologies Inc.
  • 4. Echo Therapeutics Inc.
  • 5. European Pharma Group BV
  • 6. Injex Pharma AG
  • 7. MannKind Corporation
  • 8. Medical International Technology, Inc.
  • 9. Pharmajet, Inc.
  • 10. The 3M Company

LIST OF FIGURES

  • FIGURE 1. NEEDLE FREE DIABETES CARE MARKET RESEARCH PROCESS
  • FIGURE 2. NEEDLE FREE DIABETES CARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEEDLE FREE DIABETES CARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEEDLE FREE DIABETES CARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEEDLE FREE DIABETES CARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEEDLE FREE DIABETES CARE MARKET DYNAMICS
  • TABLE 7. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN INFUSER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY CONSUMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY HOSPITALS & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NEEDLE FREE DIABETES CARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. NEEDLE FREE DIABETES CARE MARKET, FPNV POSITIONING MATRIX, 2023